Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchodilator and steroid inhalers for prevention of bronchiectasis flare-ups
ISRCTN15988757Phase 2Terminated
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of Anoro Ellipta, fluticasone and Placebo-COD Research Private Ltd in bronchiectasis (3 arms), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Number of bronchiectasis exacerbations requiring antibiotics. Started Jun 2021; status: terminated.
02
Drugs
Anoro ElliptafluticasonePlacebo-COD Research Private Ltd
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on ISRCTN15988757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15988757.